RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Overview of the Minireviews on Autophagy

      한글로보기

      https://www.riss.kr/link?id=A106037515

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      After coining the term ‘autophagy’ by Dr. Christian De Duve in 1967 during a study using glucagon-perfused liver (Deter and de Duve, 1967), researches on autophagy was slow. The discovery of autophagy genes using a yeast model revolutionized the field and ushered into the era of molecular autophagy (Noda et al., 1995). In recognition of this discovery, Yoshinori Ohsumi was awarded the Nobel Prize in Physiology or Medicine 2016. Because of extensive effort and contribution by other investigators, we now know that autophagy is indeed critical for the maintenance or rejuvenation of cellular organelles and for energy homeostasis from yeast to human. Thus, many aspects of physiological or pathological phenomena are influenced by autophagy and its dysregulation. Dysregulated autophagy appears to participate in the development of multitudes of diseases such as neurodegeneration, cancer, metabolic diseases, cardiovascular diseases, inflammatory disorders, and aging. Considering enormous implication of autophagy in cellu-lar physiology and in the pathogenesis of diverse diseases at the organismal level, the current minireview series was organized. Nakamura and Yoshimori (2018) summarized the role of autophagy in longevity and aging. Aging could be considered either as a physiological or pathological process, and would be affected by autophagy regardless of grouping. Shimizu (2018) reviewed the topic of non-canonical autophagy. In addition to classical Atg5/Atg7-dependent macroautophagy, several other types of autophagy have emerged, including unconventional autophagy that does not involve certain classical Atg genes. Fukuda and Kanki focused on mitophagy in yeast system, while Yoo and Jung (2018) summarized recent findings regarding mitophagy in mammalian system. Mitophagy is an example of selective autophagy that has implications in several important diseases such as Parkinson’s disease. Cho et al. (2018) reviewed another type of selective autophagy – pexophagy, autophagy of peroxisome which is critical in very-long chain fatty acids oxidation. While the role of lysosome in autophagy execution is well known, fate of lysosome after execution of autophagy is not well recognized. Chen and Yu (2018) addressed this point and discussed the molecular mechanism of autophagic lysosome reformation (Yu et al., 2010). Kim et al. (2018) reviewed the role of autophagy in the development of diabetes associated with obesity and also of human-type diabetes. Human diabetes is different from murine diabetes in that islet amyloid is found in > 90% of patients with human diabetes. Since amyloid-prone protein is a well-recognized substrate of autophagy, efficient autophagy could be important for normal islet function and viability. Namkoong et al. (2018) discussed about autophagy in obesity, and particularly focused on the reciprocal interaction between obesity and autophagy. Autophagy has a crucial role in the clearance of microbes through a specific phenomenon named xenophagy. Kwon and Song (2018) reviewed interaction between autophagy machinery and bacterial products from the structural perspective.
      These minireviews illustrate recent progress in understanding of the molecular mechanism of autophagy, and also potential application of this knowledge to the development of autophagy modulators that can be employed for treatment of the aforementioned diseases. Since many investigators and pharmaceutical or biotech companies are making great efforts to develop such autophagy enhancers or blockers, depending on the target diseases or processes, novel therapeutic agents that modulate autophagy will become a reality in the near future.
      번역하기

      After coining the term ‘autophagy’ by Dr. Christian De Duve in 1967 during a study using glucagon-perfused liver (Deter and de Duve, 1967), researches on autophagy was slow. The discovery of autophagy genes using a yeast model revolutionized the f...

      After coining the term ‘autophagy’ by Dr. Christian De Duve in 1967 during a study using glucagon-perfused liver (Deter and de Duve, 1967), researches on autophagy was slow. The discovery of autophagy genes using a yeast model revolutionized the field and ushered into the era of molecular autophagy (Noda et al., 1995). In recognition of this discovery, Yoshinori Ohsumi was awarded the Nobel Prize in Physiology or Medicine 2016. Because of extensive effort and contribution by other investigators, we now know that autophagy is indeed critical for the maintenance or rejuvenation of cellular organelles and for energy homeostasis from yeast to human. Thus, many aspects of physiological or pathological phenomena are influenced by autophagy and its dysregulation. Dysregulated autophagy appears to participate in the development of multitudes of diseases such as neurodegeneration, cancer, metabolic diseases, cardiovascular diseases, inflammatory disorders, and aging. Considering enormous implication of autophagy in cellu-lar physiology and in the pathogenesis of diverse diseases at the organismal level, the current minireview series was organized. Nakamura and Yoshimori (2018) summarized the role of autophagy in longevity and aging. Aging could be considered either as a physiological or pathological process, and would be affected by autophagy regardless of grouping. Shimizu (2018) reviewed the topic of non-canonical autophagy. In addition to classical Atg5/Atg7-dependent macroautophagy, several other types of autophagy have emerged, including unconventional autophagy that does not involve certain classical Atg genes. Fukuda and Kanki focused on mitophagy in yeast system, while Yoo and Jung (2018) summarized recent findings regarding mitophagy in mammalian system. Mitophagy is an example of selective autophagy that has implications in several important diseases such as Parkinson’s disease. Cho et al. (2018) reviewed another type of selective autophagy – pexophagy, autophagy of peroxisome which is critical in very-long chain fatty acids oxidation. While the role of lysosome in autophagy execution is well known, fate of lysosome after execution of autophagy is not well recognized. Chen and Yu (2018) addressed this point and discussed the molecular mechanism of autophagic lysosome reformation (Yu et al., 2010). Kim et al. (2018) reviewed the role of autophagy in the development of diabetes associated with obesity and also of human-type diabetes. Human diabetes is different from murine diabetes in that islet amyloid is found in > 90% of patients with human diabetes. Since amyloid-prone protein is a well-recognized substrate of autophagy, efficient autophagy could be important for normal islet function and viability. Namkoong et al. (2018) discussed about autophagy in obesity, and particularly focused on the reciprocal interaction between obesity and autophagy. Autophagy has a crucial role in the clearance of microbes through a specific phenomenon named xenophagy. Kwon and Song (2018) reviewed interaction between autophagy machinery and bacterial products from the structural perspective.
      These minireviews illustrate recent progress in understanding of the molecular mechanism of autophagy, and also potential application of this knowledge to the development of autophagy modulators that can be employed for treatment of the aforementioned diseases. Since many investigators and pharmaceutical or biotech companies are making great efforts to develop such autophagy enhancers or blockers, depending on the target diseases or processes, novel therapeutic agents that modulate autophagy will become a reality in the near future.

      더보기

      참고문헌 (Reference)

      1 김진영, "The Role of Autophagy in Systemic Metabolism and Human-Type Diabetes" 한국분자세포생물학회 41 (41): 11-17, 2018

      2 Yu, L., "Termination of autophagy and reformation of lysosomes regulated by mTOR" 465 : 942-946, 2010

      3 조동현, "Pexophagy: Molecular Mechanisms and Implications for Health and Diseases" 한국분자세포생물학회 41 (41): 55-64, 2018

      4 Noda, T., "Novel system for monitoring autophagy in the yeast Saccharomyces cerevisiae" 210 : 126-132, 1995

      5 Tomoyuki Fukuda, "Mechanisms and Physiological Roles of Mitophagy in Yeast" 한국분자세포생물학회 41 (41): 35-44, 2018

      6 Deter, R.L., "Influence of glucagon, an induer of cellular autophagy, on some physical properties of rat liver lysosomes" 33 : 437-449, 1967

      7 Yang Chen, "Development of Research into Autophagic Lysosome Reformation" 한국분자세포생물학회 41 (41): 45-49, 2018

      8 Shigeomi Shimizu, "Biological Roles of Alternative Autophagy" 한국분자세포생물학회 41 (41): 50-54, 2018

      9 Shuhei Nakamura, "Autophagy and Longevity" 한국분자세포생물학회 41 (41): 65-72, 2018

      10 Chun-Seok Cho, "Autophagy Dysregulation and Obesity-Associated Pathologies" 한국분자세포생물학회 41 (41): 3-10, 2018

      1 김진영, "The Role of Autophagy in Systemic Metabolism and Human-Type Diabetes" 한국분자세포생물학회 41 (41): 11-17, 2018

      2 Yu, L., "Termination of autophagy and reformation of lysosomes regulated by mTOR" 465 : 942-946, 2010

      3 조동현, "Pexophagy: Molecular Mechanisms and Implications for Health and Diseases" 한국분자세포생물학회 41 (41): 55-64, 2018

      4 Noda, T., "Novel system for monitoring autophagy in the yeast Saccharomyces cerevisiae" 210 : 126-132, 1995

      5 Tomoyuki Fukuda, "Mechanisms and Physiological Roles of Mitophagy in Yeast" 한국분자세포생물학회 41 (41): 35-44, 2018

      6 Deter, R.L., "Influence of glucagon, an induer of cellular autophagy, on some physical properties of rat liver lysosomes" 33 : 437-449, 1967

      7 Yang Chen, "Development of Research into Autophagic Lysosome Reformation" 한국분자세포생물학회 41 (41): 45-49, 2018

      8 Shigeomi Shimizu, "Biological Roles of Alternative Autophagy" 한국분자세포생물학회 41 (41): 50-54, 2018

      9 Shuhei Nakamura, "Autophagy and Longevity" 한국분자세포생물학회 41 (41): 65-72, 2018

      10 Chun-Seok Cho, "Autophagy Dysregulation and Obesity-Associated Pathologies" 한국분자세포생물학회 41 (41): 3-10, 2018

      11 권도훈, "A Structural View of Xenophagy, a Battle between Host and Microbes" 한국분자세포생물학회 41 (41): 27-34, 2018

      12 유승민, "A Molecular Approach to Mitophagy and Mitochondrial Dynamics" 한국분자세포생물학회 41 (41): 18-26, 2018

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-11-07 학술지명변경 한글명 : 분자와 세포 -> Molecules and Cells KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 2.77 0.19 1.85
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.37 1.11 0.379 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼